Physician profile
Leon D Mclaughlin
NPI 1649286188
$1,764.10
in general payments reported to CMS, 2019-2025
24 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,300 · 2020: $375 · 2021: $59.44 · 2022: $29.53.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $241.49 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $233.30 | 2019-2020 | |
| Novo Nordisk INC | $219.32 | 2019-2020 | |
| Amgen INC. | $210.20 | 2019-2020 | |
| Abbvie INC. | $88.97 | 2021-2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $87.89 | 2019 | |
| Pfizer INC. | $82.96 | 2019 | |
| Mylan Specialty L.P. | $71.99 | 2019 | |
| Astellas Pharma US INC | $69.28 | 2019-2020 | |
| Shire North American Group INC | $67.93 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $60.68 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $49.07 | 2019 | |
| Ironshore Pharmaceuticals INC. | $41.62 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $41.41 | 2019-2020 | |
| Neos Therapeutics, LP | $37.92 | 2019-2020 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Daiichi Sankyo INC. | $28.62 | 2019-2020 | |
| Avanir Pharmaceuticals, INC. | $23.62 | 2019 | |
| Amarin Pharma, INC. | $19.27 | 2020 | |
| Otsuka America Pharmaceutical, INC. | $19.27 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $17.54 | 2019 | |
| Sanofi Pasteur INC. | $14.63 | 2019 | |
| Allergan, INC. | $14.07 | 2020 | |
| Hikma Pharmaceuticals USA | $12.00 | 2019 | |
| Supernus Pharmaceuticals, INC. | $11.05 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Leon Mclaughlin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.